Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EV/Core EBITDA

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 25.2344.7216.898.4210.56

What is the latest EV/Core EBITDA ratio of NEULAND LABORATORIES ?

The latest EV/Core EBITDA ratio of NEULAND LABORATORIES is 25.23 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202625.23
Mar202544.72
Mar202416.89
Mar20238.42
Mar202210.56

How is EV/Core EBITDA of NEULAND LABORATORIES Trending?

Years EV/Core EBITDA % Change
Mar2026 25.23
-43.58
Mar2025 44.72
164.77
Mar2024 16.89
100.59
Mar2023 8.42
-20.27
Mar2022 10.56 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EV/Core EBITDA ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹27,977.2 Cr -1.9% -6.7% 44.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,562.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹244,572.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,871.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹107,770.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,829.0 Cr -0.2% 2.5% -3% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-1.9%

-6.7%

44.4%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses